NVO
$78.67
Novo Nordisk A\/S
$.63
.81%
NVO
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.80
Revenue:  $5.20 Bil
Wednesday
Aug 4
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when NVO reports earnings?
Beat
Meet
Miss

Where is NVO's stock price going from here?
Up
Flat
Down
Stock chart of NVO
Analysts
Summary of analysts' recommendations for NVO
Score
Grade
Pivots
Resistance
$79.51
$78.85
$78.44

$77.78

Support
$77.37
$76.71
$76.30
Tweet
Growth
Description
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Peers
InterCeptVertex PharmaceuticalsBioMarin PharmaceuticalRegeneron PharmaceuticalsUltragenyx PharmaceuticalBristol-Myers SquibbPfizerZoetisEli LillyMerck & Co.